 |
PDBsum entry 1af3
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Regulatory protein
|
PDB id
|
|
|
|
1af3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
272:27886-27892
(1997)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of rat Bcl-xL. Implications for the function of the Bcl-2 protein family.
|
|
M.Aritomi,
N.Kunishima,
N.Inohara,
Y.Ishibashi,
S.Ohta,
K.Morikawa.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Bcl-xL is a member of the Bcl-2 protein family, which regulates apoptosis.
Preparation of recombinant rat Bcl-xL yielded two forms, one deamidated at
-Asn-Gly- sequences to produce isoaspartates and the other not deamidated. The
crystal structures of the two forms show that they both adopt an essentially
identical backbone structure which resembles the fold of human Bcl-xL: three
layers of two alpha-helices each, capped at one end by two short helices. Both
forms have a long disordered region, which contains the potential deamidation
sites. The molecular structure exhibits a low level of interhelical
interactions, the presence of three cavities, and a notable hydrophobic cleft
surrounded by walls rich in basic residues. These unique structural features may
be favorable for its accommodation into membranes or for possible rearrangement
to modulate homo-/heterodimerization. Homology modeling of Bcl-2 and Bax, based
on the Bcl-xL structure, suggests that Bax has the strongest potential for
membrane insertion. Furthermore, we found a possible interface for interaction
with non-Bcl-2 family member proteins, such as CED-4 homologues.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Fig. 3. Stereoview of the three cavities and the -carbon
backbone. Cavities were calculated by the GRASP (42) program.
The^ view is from the bottom looking into helices 5 and 6. Cavity A
is formed by Phe^12, Leu90, Ala^93, Gly94, Phe^97, Trp137,
Ile^140, Val141, Ala^142, Phe^144, Ser145, Trp181, Ile^182,
Trp188, Phe^191, and Tyr195; cavity B by Phe^12, Leu13, Lys16,
Leu17, Lys20, Tyr22, Gly148, Cys151, and Val152; and cavity C by
Leu112, Ile^114, Thr115, Pro116, Gly117, Thr118, Phe^123,
Leu150, Ser154, Leu162, Arg165, Ile^166, and Trp169. Cavities A
and B are partitioned by the side chain of Phe^12.
|
 |
Figure 4.
Fig. 4. Stereo pairs showing the hydrophobic clefts in the
bottom region for Bcl-x[L](B) (a) and for a Bax model (b). The
hydrophobicity was mapped onto the solvent accessible surface
using the GRASP (42) program, with the hydropathy values (44).
The molecules are viewed in the same direction as in Fig. 3. The
blue color represents hydrophilic regions and the yellow
represents hydrophobic^ regions. The two red lines in a indicate
the hydrogen-bonds: Tyr22-Asp156 and Arg165-Pro116. The
three-dimensional structure of Bax was constructed by homology
modeling based on that of Bcl-x[L](B) and by using a previously
reported sequence alignment (29).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(1997,
272,
27886-27892)
copyright 1997.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
G.J.Rautureau,
C.L.Day,
and
M.G.Hinds
(2010).
Intrinsically disordered proteins in bcl-2 regulated apoptosis.
|
| |
Int J Mol Sci,
11,
1808-1824.
|
 |
|
|
|
|
 |
S.Noguchi
(2010).
Isomerization mechanism of aspartate to isoaspartate implied by structures of Ustilago sphaerogena ribonuclease U2 complexed with adenosine 3'-monophosphate.
|
| |
Acta Crystallogr D Biol Crystallogr,
66,
843-849.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.R.Rockwell,
and
B.T.Huber
(2009).
Biologically distinct conformations of Bcl-x can be resolved using 2D isoelectric focusing.
|
| |
Mol Immunol,
46,
1605-1612.
|
 |
|
|
|
|
 |
Y.Zhan,
G.Jia,
D.Wu,
Y.Xu,
and
L.Xu
(2009).
Design and synthesis of a gossypol derivative with improved antitumor activities.
|
| |
Arch Pharm (Weinheim),
342,
223-229.
|
 |
|
|
|
|
 |
A.A.Arnold,
A.Aboukameel,
J.Chen,
D.Yang,
S.Wang,
A.Al-Katib,
and
R.M.Mohammad
(2008).
Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model.
|
| |
Mol Cancer,
7,
20.
|
 |
|
|
|
|
 |
B.Ku,
J.S.Woo,
C.Liang,
K.H.Lee,
H.S.Hong,
X.E,
K.S.Kim,
J.U.Jung,
and
B.H.Oh
(2008).
Structural and biochemical bases for the inhibition of autophagy and apoptosis by viral BCL-2 of murine gamma-herpesvirus 68.
|
| |
PLoS Pathog,
4,
e25.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Sun,
Z.M.Li,
Z.Y.Hu,
X.B.Lin,
N.N.Zhou,
L.J.Xian,
D.J.Yang,
and
W.Q.Jiang
(2008).
ApoG2 inhibits antiapoptotic Bcl-2 family proteins and induces mitochondria-dependent apoptosis in human lymphoma U937 cells.
|
| |
Anticancer Drugs,
19,
967-974.
|
 |
|
|
|
|
 |
S.Asoh,
and
S.Ohta
(2008).
PTD-mediated delivery of anti-cell death proteins/peptides and therapeutic enzymes.
|
| |
Adv Drug Deliv Rev,
60,
499-516.
|
 |
|
|
|
|
 |
A.J.García-Sáez,
S.Chiantia,
J.Salgado,
and
P.Schwille
(2007).
Pore formation by a Bax-derived peptide: effect on the line tension of the membrane probed by AFM.
|
| |
Biophys J,
93,
103-112.
|
 |
|
|
|
|
 |
R.Zhao,
D.Oxley,
T.S.Smith,
G.A.Follows,
A.R.Green,
and
D.R.Alexander
(2007).
DNA damage-induced Bcl-xL deamidation is mediated by NHE-1 antiport regulated intracellular pH.
|
| |
PLoS Biol,
5,
e1.
|
 |
|
|
|
|
 |
C.Wang,
D.A.Neff,
J.G.Krolikowski,
D.Weihrauch,
M.Bienengraeber,
D.C.Warltier,
J.R.Kersten,
and
P.S.Pagel
(2006).
The influence of B-cell lymphoma 2 protein, an antiapoptotic regulator of mitochondrial permeability transition, on isoflurane-induced and ischemic postconditioning in rabbits.
|
| |
Anesth Analg,
102,
1355-1360.
|
 |
|
|
|
|
 |
O.Kutuk,
and
H.Basaga
(2006).
Bcl-2 protein family: implications in vascular apoptosis and atherosclerosis.
|
| |
Apoptosis,
11,
1661-1675.
|
 |
|
|
|
|
 |
D.A.Hildeman
(2004).
Regulation of T-cell apoptosis by reactive oxygen species.
|
| |
Free Radic Biol Med,
36,
1496-1504.
|
 |
|
|
|
|
 |
R.Zhao,
F.T.Yang,
and
D.R.Alexander
(2004).
An oncogenic tyrosine kinase inhibits DNA repair and DNA-damage-induced Bcl-xL deamidation in T cell transformation.
|
| |
Cancer Cell,
5,
37-49.
|
 |
|
|
|
|
 |
A.Clerk,
S.M.Cole,
T.E.Cullingford,
J.G.Harrison,
M.Jormakka,
and
D.M.Valks
(2003).
Regulation of cardiac myocyte cell death.
|
| |
Pharmacol Ther,
97,
223-261.
|
 |
|
|
|
|
 |
M.G.Hinds,
M.Lackmann,
G.L.Skea,
P.J.Harrison,
D.C.Huang,
and
C.L.Day
(2003).
The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity.
|
| |
EMBO J,
22,
1497-1507.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.E.Deverman,
B.L.Cook,
S.R.Manson,
R.A.Niederhoff,
E.M.Langer,
I.Rosová,
L.A.Kulans,
X.Fu,
J.S.Weinberg,
J.W.Heinecke,
K.A.Roth,
and
S.J.Weintraub
(2002).
Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage.
|
| |
Cell,
111,
51-62.
|
 |
|
|
|
|
 |
S.Asoh,
I.Ohsawa,
T.Mori,
K.Katsura,
T.Hiraide,
Y.Katayama,
M.Kimura,
D.Ozaki,
K.Yamagata,
and
S.Ohta
(2002).
Protection against ischemic brain injury by protein therapeutics.
|
| |
Proc Natl Acad Sci U S A,
99,
17107-17112.
|
 |
|
|
|
|
 |
Z.Huang
(2002).
The chemical biology of apoptosis. Exploring protein-protein interactions and the life and death of cells with small molecules.
|
| |
Chem Biol,
9,
1059-1072.
|
 |
|
|
|
|
 |
U.Sartorius,
I.Schmitz,
and
P.H.Krammer
(2001).
Molecular mechanisms of death-receptor-mediated apoptosis.
|
| |
Chembiochem,
2,
20-29.
|
 |
|
|
|
|
 |
I.Schmitz,
S.Kirchhoff,
and
P.H.Krammer
(2000).
Regulation of death receptor-mediated apoptosis pathways.
|
| |
Int J Biochem Cell Biol,
32,
1123-1136.
|
 |
|
|
|
|
 |
M.del Mar Martínez-Senac,
S.Corbalán-García,
and
J.C.Gómez-Fernández
(2000).
Study of the secondary structure of the C-terminal domain of the antiapoptotic protein bcl-2 and its interaction with model membranes.
|
| |
Biochemistry,
39,
7744-7752.
|
 |
|
|
|
|
 |
R.Nanbu-Wakao,
S.Asoh,
K.Nishimaki,
R.Tanaka,
and
S.Ohta
(2000).
Bacterial cell death induced by human pro-apoptotic Bax is blocked by an RNase E mutant that functions in an anti-oxidant pathway.
|
| |
Genes Cells,
5,
155-167.
|
 |
|
|
|
|
 |
S.Conus,
T.Kaufmann,
I.Fellay,
I.Otter,
T.Rossé,
and
C.Borner
(2000).
Bcl-2 is a monomeric protein: prevention of homodimerization by structural constraints.
|
| |
EMBO J,
19,
1534-1544.
|
 |
|
|
|
|
 |
H.Bruhn,
and
M.Leippe
(1999).
Comparative modeling of amoebapores and granulysin based on the NK-lysin structure-structural and functional implications.
|
| |
Biol Chem,
380,
1001-1007.
|
 |
|
|
|
|
 |
R.A.Kinloch,
J.M.Treherne,
L.M.Furness,
and
I.Hajimohamadreza
(1999).
The pharmacology of apoptosis.
|
| |
Trends Pharmacol Sci,
20,
35-42.
|
 |
|
|
|
|
 |
S.Desagher,
A.Osen-Sand,
A.Nichols,
R.Eskes,
S.Montessuit,
S.Lauper,
K.Maundrell,
B.Antonsson,
and
J.C.Martinou
(1999).
Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis.
|
| |
J Cell Biol,
144,
891-901.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |